Rituximab for eradicating inhibitors in people with acquired haemophilia A (Q26471152)

2 July 2019

review article

1 reference

title

Rituximab for eradicating inhibitors in people with acquired haemophilia A (English)

1 reference

2 July 2019

0 references

0 references

1 reference

Yan Zeng

1 reference

2 July 2019

Ruiqing Zhou

series ordinal

1 reference

2 July 2019

Xin Duan

series ordinal

1 reference

2 July 2019

Dan Long

series ordinal

1 reference

2 July 2019

publication date

8 July 2016

1 reference

2 July 2019

Cochrane Database of Systematic Reviews

published in

1 reference

2 July 2019

volume

1 reference

2 July 2019

page(s)

CD011907

1 reference

2 July 2019

Rituximab-induced long-term remission in patients with refractory acquired hemophilia

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Rituximab for autoimmune haemophilia: a proposed treatment algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Bullous pemphigoid associated with acquired hemophilia a: a rare association of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Single-center experience with rituximab as first-line immunosuppression for acquired hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired hemophilia in association with ANCA-associated vasculitis: response to rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired hemophilia a successfully treated with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Postpartum acquired haemophilia: a single centre experience with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired high-titer factor VIII inhibitor: fatal bleeding despite multimodal treatment including rituximab preceded by multiple plasmaphereses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Rituximab in the treatment of adult acquired hemophilia A: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired factor VIII inhibitors in oncohematology: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired hemophilia in pediatrics: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Inhibitor eradication with rituximab in haemophilia: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Factor VIII inhibitor associated with peginterferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

A study of 65 patients with acquired hemophilia A in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Life-threatening bleeding from refractory acquired FVIII inhibitor successfully treated with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Treatment of refractory autoimmune (acquired) haemophilia with anti-CD20 (rituximab).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Rituximab in postpartum-related acquired hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

A rapidly progressive, life-threatening postpartum hemorrhage: successful treatment with anti-CD-20 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Rituximab for the treatment of acquired antibodies to factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Rituximab in the treatment of acquired hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Rituximab in the treatment of acquired factor VIII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired factor VIII inhibitor as initial manifestation of collagen vascular disease: response to combination immunosuppression as first-line therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Low-dose rituximab in the treatment of acquired haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired hemophilia possibly induced by etanercept in a patient with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Diagnosis and treatment of acquired haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired haemophilia treated successfully with rituximab in a patient with pemphigus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Treatment of acquired hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Consensus recommendations for the diagnosis and treatment of acquired hemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Management of acquired haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Successful treatment with rituximab in an elderly patient with acquired factor VIII inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired haemophilia A in a patient with systemic sclerosis treated with autologous haematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Successful treatment of acquired hemophilia a with rituximab and steroids in a 5-year-old girl

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired hemophilia A: a concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired factor VIII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Rituximab in the treatment of autoimmune haematological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired hemophilia A with sigmoid colon cancer: successful treatment with rituximab followed by sigmoidectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Rituximab for managing acquired hemophilia A in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired haemophilia A treated with Rituximab in a patient with prostatic melioidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Clinical trials and rare diseases: a way out of a conundrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Health care costing: data, methods, current applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired haemophilia A after stem cell transplant for sickle cell disease: treatment with recombinant porcine factor VIII (OBI-1) and tolerance induction with rituximab/prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired haemophilia in HIV negative, HHV-8 positive multicentric Castleman's disease: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired haemophilia in association with organ-specific autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: case report and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Successful rituximab therapy of acquired factor VIII inhibitor in a patient with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Management of postoperative hemorrhage associated with factor VIII inhibitor: report of a case.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Management of acquired haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Rituximab in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Immune tolerance therapy in patients with acquired hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Successful treatment of a patient with acquired haemophilia A with a combination of a low-dose rituximab and recombinant human FVIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Successful treatment of acquired haemophilia in a patient with bullous pemphigoid with single-dosing regimen of rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

Acquired hemophilia: a critical bleeding syndrome

21 January 2018

1 reference

12 December 2020

Rituximab in the treatment of acquired factor VIII inhibitors

1 reference

12 December 2020

The efficacy of rituximab in the treatment of inhibitor-associated hemostatic disorders

1 reference

12 December 2020

[Efficiency of rituximab in acquired hemophilia: report of two cases and review of literature]

1 reference

12 December 2020

Efficacy of rituximab treatment in postpartum acquired haemophilia A.

1 reference

12 December 2020

[Acquired haemophilia].

1 reference

12 December 2020

Registries for robust evidence

1 reference

12 December 2020

Rituximab in the treatment of acquired haemophilia A in a patient with polymyalgia rheumatica

1 reference

12 December 2020

[Successful treatment of an acquired hemophilia A patient with rituximab]

1 reference

12 December 2020

Durable responses to rituximab in acquired factor VIII deficiency

1 reference

12 December 2020

Long-term response to rituximab in a patient with acquired hemophilia

1 reference

12 December 2020

Acquired hemophilia A treated with rituximab. Report of one case

1 reference

12 December 2020

[Clinical evaluation of three elderly cases with acquired hemophilia A]

1 reference

12 December 2020

Acquired haemophilia secondary to ivabradine presenting with acute respiratory distress syndrome

1 reference

12 December 2020

[Acquired hemophilia A in prepartum: case report and literature review]

1 reference

12 December 2020

Therapeutic challenges in acquired factor VIII deficiency

1 reference

12 December 2020

[A case history of acquired haemophilia A]

1 reference

12 December 2020

Acquired haemophilia A in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribarivin: role of rituximab

1 reference

12 December 2020

Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literature

1 reference

12 December 2020

[A single-center clinical study of 22 patients with acquired hemophilia].

1 reference

12 December 2020

Successful immunoadsorption of life-threatening bleeding in factor VIII inhibitor disease, but no long-term remission with anti-CD20 treatment

1 reference

12 December 2020

The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A

1 reference

12 December 2020

Successful treatment with rituximab of a patient with coincident acquired hemophilia A and thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy

1 reference

12 December 2020

A survey of 215 non-hemophilic patients with inhibitors to Factor VIII

1 reference

12 December 2020

A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies

1 reference

12 December 2020

Coagulation disorders - recent lessons from clinical conditions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011907.PUB2

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD011907.PUB2

1 reference

2 July 2019

PMC publication ID

6458002

1 reference

2 July 2019

PubMed publication ID

27387850

1 reference

2 July 2019